{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:16:32Z","timestamp":1740125792986,"version":"3.37.3"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1R01 DA047347-01","K01 DA049950"],"award-info":[{"award-number":["1R01 DA047347-01","K01 DA049950"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR003017"],"award-info":[{"award-number":["UL1TR003017"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11606-022-07991-7","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T17:02:56Z","timestamp":1673024576000},"page":"1862-1870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of a State Prescribing Limits Policy with Opioid Prescribing and Long-term Use: an Interrupted Time Series Analysis"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9360-2454","authenticated-orcid":false,"given":"Peter","family":"Treitler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary","family":"Samples","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Hermida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"7991_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","volume":"71","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183-188. https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.010","journal-title":"Int J Drug Policy."},{"issue":"4","key":"7991_CR2","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1360-0443.2012.04005.x","volume":"108","author":"S Minozzi","year":"2013","unstructured":"Minozzi S, Amato L, Davoli M. Development of dependence following treatment with opioid analgesics for pain relief: a systematic review. Addiction. 2013;108(4):688-698. https:\/\/doi.org\/10.1111\/j.1360-0443.2012.04005.x","journal-title":"Addiction."},{"issue":"10","key":"7991_CR3","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1111\/add.15487","volume":"116","author":"SE Hadland","year":"2021","unstructured":"Hadland SE, Bagley SM, Gai MJ, et al. Opioid use disorder and overdose among youth following an initial opioid prescription. Addiction. 2021;116(10):2790-2800. https:\/\/doi.org\/10.1111\/add.15487","journal-title":"Addiction."},{"issue":"2","key":"7991_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/pm\/pnz038","volume":"21","author":"SE Heins","year":"2019","unstructured":"Heins SE, Frey KP, Alexander GC, Castillo RC. Reducing high-dose opioid prescribing: state-level morphine equivalent daily dose policies, 2007\u20132017. Pain Med. 2019;21(2):308-316. https:\/\/doi.org\/10.1093\/pm\/pnz038","journal-title":"Pain Med."},{"issue":"7","key":"7991_CR5","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1111\/add.15359","volume":"116","author":"CS Davis","year":"2020","unstructured":"Davis CS, Lieberman AJ. Laws limiting prescribing and dispensing of opioids in the United States, 1989-2019. Addiction. 2020;116(7):1817-1827. https:\/\/doi.org\/10.1111\/add.15359","journal-title":"Addiction."},{"issue":"20","key":"7991_CR6","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1056\/NEJMra025411","volume":"349","author":"JC Ballantyne","year":"2003","unstructured":"Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349(20):1943-1953. https:\/\/doi.org\/10.1056\/NEJMra025411","journal-title":"N Engl J Med."},{"issue":"15","key":"7991_CR7","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016. JAMA. 2016;315(15):1624-1645. https:\/\/doi.org\/10.1001\/jama.2016.1464","journal-title":"JAMA."},{"issue":"4","key":"7991_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.2361","volume":"3","author":"ME Tori","year":"2020","unstructured":"Tori ME, Larochelle MR, Naimi TS. Alcohol or benzodiazepine co-involvement with opioid overdose deaths in the United States, 1999-2017. JAMA Netw Open. 2020;3(4):e202361. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.2361","journal-title":"JAMA Netw Open."},{"issue":"1","key":"7991_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/PME.12907","volume":"17","author":"N Dasgupta","year":"2016","unstructured":"Dasgupta N, Funk MJ, Proescholdbell S, Hirsch A, Ribisl KM, Marshall S. Cohort study of the impact of high-dose opioid analgesics on overdose mortality. Pain Med. 2016;17(1):85-98. https:\/\/doi.org\/10.1111\/PME.12907","journal-title":"Pain Med."},{"key":"7991_CR10","unstructured":"New Jersey Division of Consumer Affairs. Limitations on Prescribing, Administering, or Dispensing of Controlled Dangerous Substances, and Special Requirements for Management of Acute and Chronic Pain: Physicians, Podiatrists, Physician Assistants, and Certified Nurse Midwives. Published March 20, 2017. Accessed December 28, 2022. https:\/\/www.njconsumeraffairs.gov\/Proposals\/Pages\/03202017-bme-proposal.aspx"},{"key":"7991_CR11","unstructured":"New Jersey Substance Use Disorder Law. Chapter 28 P.L. 2017. Accessed December 28, 2022. https:\/\/nj.gov\/treasury\/pensions\/documents\/laws\/chapter28-2017.pdf"},{"key":"7991_CR12","doi-asserted-by":"publisher","first-page":"109232","DOI":"10.1016\/j.drugalcdep.2021.109232","volume":"231","author":"BD Stein","year":"2022","unstructured":"Stein BD, Sheng F, Taylor EA, Dick AW, Sorbero M, Pacula RL. The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic. Drug Alcohol Depend. 2022;231:109232. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109232","journal-title":"Drug Alcohol Depend."},{"key":"7991_CR13","doi-asserted-by":"publisher","first-page":"102397","DOI":"10.1016\/j.jhealeco.2020.102397","volume":"76","author":"DW Sacks","year":"2021","unstructured":"Sacks DW, Hollingsworth A, Nguyen T, Simon K. Can policy affect initiation of addictive substance use? Evidence from opioid prescribing. J Health Econ. 2021;76:102397. https:\/\/doi.org\/10.1016\/j.jhealeco.2020.102397","journal-title":"J Health Econ."},{"issue":"11","key":"7991_CR14","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1007\/s11606-019-05150-z","volume":"34","author":"CV Dave","year":"2019","unstructured":"Dave CV, Patorno E, Franklin JM, et al. Impact of state laws restricting opioid duration on characteristics of new opioid prescriptions. J Gen Intern Med. 2019;34(11):2339-2341. https:\/\/doi.org\/10.1007\/s11606-019-05150-z","journal-title":"J Gen Intern Med."},{"issue":"2","key":"7991_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.0234","volume":"3","author":"JM Hincapie-Castillo","year":"2020","unstructured":"Hincapie-Castillo JM, Goodin A, Possinger MC, Usmani SA, Vouri SM. Changes in opioid use after Florida\u2019s restriction law for acute pain prescriptions. JAMA Netw Open. 2020;3(2):e200234. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.0234","journal-title":"JAMA Netw Open."},{"issue":"8","key":"7991_CR16","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1093\/pm\/pnab017","volume":"22","author":"JM Hincapie-Castillo","year":"2021","unstructured":"Hincapie-Castillo JM, Easey T, Hernandez C, et al. Changes in quantity of opioids dispensed following Florida\u2019s restriction law for acute pain prescriptions. Pain Med. 2021;22(8):1870-1876. https:\/\/doi.org\/10.1093\/pm\/pnab017","journal-title":"Pain Med."},{"issue":"8","key":"7991_CR17","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1007\/s11606-021-06966-4","volume":"37","author":"IL Valdes","year":"2021","unstructured":"Valdes IL, Possinger MC, Hincapie-Castillo JM, et al. Changes in prescribing by provider type following a state prescription opioid restriction law. J Gen Intern Med. 2021;37(8):1838-1844. https:\/\/doi.org\/10.1007\/s11606-021-06966-4","journal-title":"J Gen Intern Med."},{"issue":"4","key":"7991_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.spinee.2018.09.007","volume":"19","author":"DBC Reid","year":"2019","unstructured":"Reid DBC, Shah KN, Ruddell JH, et al. Effect of narcotic prescription limiting legislation on opioid utilization following lumbar spine surgery. Spine J. 2019;19(4):717-725. https:\/\/doi.org\/10.1016\/j.spinee.2018.09.007","journal-title":"Spine J."},{"issue":"3","key":"7991_CR19","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1093\/pm\/pnz159","volume":"21","author":"CS Davis","year":"2020","unstructured":"Davis CS, Piper BJ, Gertner AK, Rotter JS. Opioid prescribing laws are not associated with short-term declines in prescription opioid distribution. Pain Med. 2020;21(3):532-537. https:\/\/doi.org\/10.1093\/pm\/pnz159","journal-title":"Pain Med."},{"issue":"5","key":"7991_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.7326\/M21-4363","volume":"175","author":"EE McGinty","year":"2022","unstructured":"McGinty EE, Bicket MC, Seewald NJ, et al. Effects of state opioid prescribing laws on use of opioid and other pain treatments among commercially insured U.S. adults. Ann Intern Med. 2022;175(5):617-627. https:\/\/doi.org\/10.7326\/M21-4363","journal-title":"Ann Intern Med."},{"issue":"12","key":"7991_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.18361","volume":"2","author":"S Agarwal","year":"2019","unstructured":"Agarwal S, Bryan JD, Hu HM, et al. Association of state opioid duration limits with postoperative opioid prescribing. JAMA Netw Open. 2019;2(12):e1918361. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.18361","journal-title":"JAMA Netw Open."},{"key":"7991_CR22","unstructured":"First Databank. FDB MedKnowledge. Published 2022. Accessed December 28, 2022. https:\/\/www.fdbhealth.com\/solutions\/medknowledge-drug-database"},{"key":"7991_CR23","unstructured":"Unite Sates Census Bureau. X-13ARIMA-SEATS Seasonal Adjustment Program. Published July 11, 2022. Accessed December 28, 2022. https:\/\/www.census.gov\/data\/software\/x13as.html"},{"key":"7991_CR24","unstructured":"Sax C. Seasonal: R interface to X-13-ARIMA-SEATS. Published online August 6, 2016. Accessed June 3, 2022. https:\/\/cran.microsoft.com\/snapshot\/2016-10-23\/web\/packages\/seasonal\/vignettes\/seas.pdf"},{"key":"7991_CR25","volume-title":"Time Series Analysis: Forecasting and Control","author":"GEP Box","year":"2015","unstructured":"Box GEP, Jenkins GM, Reinsel GC, Ljung GM. Time Series Analysis: Forecasting and Control. John Wiley & Sons; 2015."},{"issue":"6","key":"7991_CR26","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1093\/ije\/dyy135","volume":"47","author":"J Lopez Bernal","year":"2018","unstructured":"Lopez Bernal J, Cummins S, Gasparrini A. The use of controls in interrupted time series studies of public health interventions. Int J Epidemiol. 2018;47(6):2082-2093. https:\/\/doi.org\/10.1093\/ije\/dyy135","journal-title":"Int J Epidemiol."},{"issue":"6","key":"7991_CR27","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/j.1365-2753.2010.01504.x","volume":"17","author":"A Linden","year":"2011","unstructured":"Linden A, Adams JL. Applying a propensity score-based weighting model to interrupted time series data: improving causal inference in programme evaluation. J Eval Clin Pract. 2011;17(6):1231-1238. https:\/\/doi.org\/10.1111\/j.1365-2753.2010.01504.x","journal-title":"J Eval Clin Pract."},{"issue":"3","key":"7991_CR28","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.amepre.2020.09.015","volume":"60","author":"SI Ranapurwala","year":"2021","unstructured":"Ranapurwala SI, Ringwalt CL, Pence BW, et al. State Medical Board policy and opioid prescribing: a controlled interrupted time series. Am J Prev Med. 2021;60(3):343-351. https:\/\/doi.org\/10.1016\/j.amepre.2020.09.015","journal-title":"Am J Prev Med."},{"issue":"6","key":"7991_CR29","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/j.1365-2753.2009.01201.x","volume":"15","author":"RJ Shackelton","year":"2009","unstructured":"Shackelton RJ, Marceau LD, Link CL, McKinlay JB. The intended and unintended consequences of clinical guidelines. J Eval Clin Pract. 2009;15(6):1035-1042. https:\/\/doi.org\/10.1111\/j.1365-2753.2009.01201.x","journal-title":"J Eval Clin Pract."},{"key":"7991_CR30","doi-asserted-by":"publisher","unstructured":"Alalouf M, Miller S, Wherry LR. What Difference Does a Diagnosis Make? Evidence from Marginal Patients. Published online October 2019. https:\/\/doi.org\/10.3386\/w26363","DOI":"10.3386\/w26363"},{"issue":"2","key":"7991_CR31","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1162\/qjec.2010.125.2.591","volume":"125","author":"D Almond","year":"2010","unstructured":"Almond D, Doyle JJ Jr, Kowalski AE, Williams H. Estimating marginal returns to medical care: evidence from at-risk newborns*. Q J Econ. 2010;125(2):591-634. https:\/\/doi.org\/10.1162\/qjec.2010.125.2.591","journal-title":"Q J Econ."},{"issue":"5","key":"7991_CR32","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1001\/jama.281.5.446","volume":"281","author":"ES Fisher","year":"1999","unstructured":"Fisher ES, Welch HG. Avoiding the unintended consequences of growth in medical care: how might more be worse? JAMA. 1999;281(5):446-453. https:\/\/doi.org\/10.1001\/jama.281.5.446","journal-title":"JAMA."},{"issue":"4","key":"7991_CR33","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/ADD.15698","volume":"117","author":"GC Alexander","year":"2021","unstructured":"Alexander GC, Ballreich J, Mansour O, Dowdy DW. Effect of reductions in opioid prescribing on opioid use disorder and fatal overdose in the United States: a dynamic Markov model. Addiction. 2021;117(4):969-976. https:\/\/doi.org\/10.1111\/ADD.15698","journal-title":"Addiction."},{"issue":"6","key":"7991_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.annemergmed.2017.03.057","volume":"70","author":"SG Weiner","year":"2017","unstructured":"Weiner SG, Baker O, Poon SJ, et al. The effect of opioid prescribing guidelines on prescriptions by emergency physicians in Ohio. Ann Emerg Med. 2017;70(6):799-808.e1. https:\/\/doi.org\/10.1016\/j.annemergmed.2017.03.057","journal-title":"Ann Emerg Med."},{"issue":"5","key":"7991_CR35","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jpain.2015.12.018","volume":"17","author":"MD Sullivan","year":"2016","unstructured":"Sullivan MD, Bauer AM, Fulton-Kehoe D, et al. Trends in opioid dosing among Washington state Medicaid patients before and after opioid dosing guideline implementation. J Pain. 2016;17(5):561-568. https:\/\/doi.org\/10.1016\/j.jpain.2015.12.018","journal-title":"J Pain."},{"issue":"6","key":"7991_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.7326\/M18-1243","volume":"169","author":"ASB Bohnert","year":"2018","unstructured":"Bohnert ASB, Guy GP, Losby JL. Opioid prescribing in the United States before and after the centers for disease control and prevention\u2019s 2016 opioid guideline. Ann Intern Med. 2018;169(6):367-375. https:\/\/doi.org\/10.7326\/M18-1243","journal-title":"Ann Intern Med."},{"issue":"7","key":"7991_CR37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/jama.2019.0010","volume":"321","author":"KP Chua","year":"2019","unstructured":"Chua KP, Brummett CM, Waljee JF. Opioid prescribing limits for acute pain: potential problems with design and implementation. JAMA. 2019;321(7):643-644. https:\/\/doi.org\/10.1001\/jama.2019.0010","journal-title":"JAMA."},{"key":"7991_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.drugpo.2019.01.015","volume":"66","author":"T Antoniou","year":"2019","unstructured":"Antoniou T, Ala-Leppilampi K, Shearer D, Parsons JA, Tadrous M, Gomes T. \u201cLike being put on an ice floe and shoved away\u201d: a qualitative study of the impacts of opioid-related policy changes on people who take opioids. Int J Drug Policy. 2019;66:15-22. https:\/\/doi.org\/10.1016\/j.drugpo.2019.01.015","journal-title":"Int J Drug Policy."},{"issue":"11","key":"7991_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015083","volume":"7","author":"MA Achkar","year":"2017","unstructured":"Achkar MA, Revere D, Dennis B, MacKie P, Gupta S, Grannis S. Exploring perceptions and experiences of patients who have chronic pain as state prescription opioid policies change: a qualitative study in Indiana. BMJ Open. 2017;7(11):e015083. https:\/\/doi.org\/10.1136\/bmjopen-2016-015083","journal-title":"BMJ Open."},{"key":"7991_CR40","doi-asserted-by":"publisher","first-page":"109342","DOI":"10.1016\/j.drugalcdep.2022.109342","volume":"233","author":"DM Walker","year":"2022","unstructured":"Walker DM, Childerhose JE, Chen S, et al. Exploring perspectives on changing opioid prescribing practices: a qualitative study of community stakeholders in the HEALing Communities Study. Drug Alcohol Depend. 2022;233:109342. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109342","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"7991_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/08897077.2017.1296524","volume":"38","author":"EE Hurstak","year":"2017","unstructured":"Hurstak EE, Kushel M, Chang J, et al. The risks of opioid treatment: perspectives of primary care practitioners and patients from safety-net clinics. Subst Abuse. 2017;38(2):213-221. https:\/\/doi.org\/10.1080\/08897077.2017.1296524","journal-title":"Subst Abuse."},{"issue":"5","key":"7991_CR42","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1001\/jamainternmed.2016.0544","volume":"176","author":"BT Bateman","year":"2016","unstructured":"Bateman BT, Choudhry NK. Limiting the duration of opioid prescriptions: balancing excessive prescribing and the effective treatment of pain. JAMA Intern Med. 2016;176(5):583-584. https:\/\/doi.org\/10.1001\/jamainternmed.2016.0544","journal-title":"JAMA Intern Med."},{"issue":"10","key":"7991_CR43","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2105\/AJPH.2018.304590","volume":"108","author":"AL Pitt","year":"2018","unstructured":"Pitt AL, Humphreys K, Brandeau ML. Modeling health benefits and harms of public policy responses to the US opioid epidemic. Am J Public Health. 2018;108(10):1394-1400. https:\/\/doi.org\/10.2105\/AJPH.2018.304590","journal-title":"Am J Public Health."},{"issue":"1","key":"7991_CR44","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/24740527.2021.1881886","volume":"5","author":"L Dassieu","year":"2021","unstructured":"Dassieu L, Heino A, Develay \u00c9, et al. \u201cThey think you\u2019re trying to get the drug\u201d: qualitative investigation of chronic pain patients\u2019 health care experiences during the opioid overdose epidemic in Canada. Can J Pain. 2021;5(1):66-80. https:\/\/doi.org\/10.1080\/24740527.2021.1881886","journal-title":"Can J Pain."},{"issue":"4","key":"7991_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1257\/pol.20170082","volume":"10","author":"A Alpert","year":"2018","unstructured":"Alpert A, Powell D, Pacula RL. Supply-side drug policy in the presence of substitutes: evidence from the introduction of abuse-deterrent opioids. Am Econ J Econ Policy. 2018;10(4):1-35. https:\/\/doi.org\/10.1257\/pol.20170082","journal-title":"Am Econ J Econ Policy."},{"issue":"1","key":"7991_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/j.pain.0000000000002298","volume":"163","author":"SE Hallvik","year":"2022","unstructured":"Hallvik SE, El Ibrahimi S, Johnston K, et al. Patient outcomes after opioid dose reduction among patients with chronic opioid therapy. Pain. 2022;163(1):83-90. https:\/\/doi.org\/10.1097\/j.pain.0000000000002298","journal-title":"Pain."},{"issue":"5","key":"7991_CR47","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jama.2021.11013","volume":"326","author":"A Agnoli","year":"2021","unstructured":"Agnoli A, Xing G, Tancredi DJ, Magnan E, Jerant A, Fenton JJ. Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids. JAMA. 2021;326(5):411-419. https:\/\/doi.org\/10.1001\/jama.2021.11013","journal-title":"JAMA."},{"issue":"12","key":"7991_CR48","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/S11606-019-05301-2\/FIGURES\/1","volume":"34","author":"JR James","year":"2019","unstructured":"James JR, Scott JAM, Klein JW, et al. Mortality after discontinuation of primary care\u2013based chronic opioid therapy for pain: a retrospective cohort study. J Gen Intern Med. 2019;34(12):2749-2755. https:\/\/doi.org\/10.1007\/S11606-019-05301-2\/FIGURES\/1","journal-title":"J Gen Intern Med."},{"key":"7991_CR49","doi-asserted-by":"publisher","unstructured":"Oliva EM, Bowe T, Manhapra A, et al. Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation. The BMJ. 2020;368. https:\/\/doi.org\/10.1136\/bmj.m283","DOI":"10.1136\/bmj.m283"},{"issue":"2","key":"7991_CR50","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11673-020-09982-x","volume":"17","author":"JH Marks","year":"2020","unstructured":"Marks JH. Lessons from corporate influence in the opioid epidemic: toward a norm of separation. J Bioethical Inq. 2020;17(2):173-189. https:\/\/doi.org\/10.1007\/s11673-020-09982-x","journal-title":"J Bioethical Inq."},{"issue":"21","key":"7991_CR51","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1001\/jama.2019.5188","volume":"321","author":"R Rubin","year":"2019","unstructured":"Rubin R. Limits on opioid prescribing leave patients with chronic pain vulnerable. JAMA. 2019;321(21):2059-2062. https:\/\/doi.org\/10.1001\/jama.2019.5188","journal-title":"JAMA."},{"key":"7991_CR52","unstructured":"Centers for Disease Control and Prevention. Proposed 2022 CDC Clinical Practice Guideline for Prescribing Opioids. Published online February 10, 2022. Accessed June 3, 2022. https:\/\/www.federalregister.gov\/documents\/2022\/02\/10\/2022-02802\/proposed-2022-cdc-clinical-practice-guideline-for-prescribing-opioids"},{"key":"7991_CR53","doi-asserted-by":"publisher","unstructured":"Samples H. Commentary on Lo-Ciganic et al.: The importance of evidence-based clinical and policy approaches to reduce opioid harms. Addiction. Published online May 11, 2022. https:\/\/doi.org\/10.1111\/add.15915","DOI":"10.1111\/add.15915"},{"issue":"1","key":"7991_CR54","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1001\/jamapsychiatry.2021.3136","volume":"79","author":"C Blanco","year":"2022","unstructured":"Blanco C, Wall MM, Olfson M. Expanding current approaches to solve the opioid crisis. JAMA Psychiatry. 2022;79(1):5. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.3136","journal-title":"JAMA Psychiatry."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-022-07991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-022-07991-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-022-07991-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T01:10:45Z","timestamp":1704503445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-022-07991-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["7991"],"URL":"https:\/\/doi.org\/10.1007\/s11606-022-07991-7","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"type":"print","value":"0884-8734"},{"type":"electronic","value":"1525-1497"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"assertion":[{"value":"21 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Samples received consulting fees from the American Society of Addiction Medicine outside the submitted work. The remaining authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}